RxSightRXST -2.85%68 Days Inventory is 409.84 as of Mar. 2026, which is 133% above its 10-year median of 175.58. GuruFocus rates RXST with a GF Score™ of 68/100 and a GF Value™ of $35.80 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 788 Medical Devices & Instruments companies, RxSight ranks worse than 83.38% on this metric.
Days Inventory is also known as Days Sales of Inventory (DSI). RxSight's Average Total Inventories for the
three
months ended in Mar. 2026 was $33.2 Mil. RxSight's Cost of Goods Sold for the
three
months ended in Mar. 2026 was $7.4 Mil.
Hence, RxSight's Days Inventory for the
three
months ended in Mar. 2026 was 409.84.
The historical rank and industry rank for RxSight's Days Inventory or its related term are showing as below:
RXST'
s Days Inventory Range Over the Past 10 Years
Min: 150.78 Med: 175.58 Max: 649
Current: 358.8
During the past 7 years, RxSight's highest Days Inventory was 649.00. The lowest was 150.78. And the median was 175.58.
RXST's Days Inventory is ranked worse than 83.38% of 788
companies
in the Medical Devices & Instruments industry
Industry Median: 179.115
vs RXST: 358.80
RxSight's Days Inventory
increased
from Mar. 2025 (217.41) to Mar. 2026 (409.84).
It might indicate that RxSight's sales slowed down.
Warning Sign:
If a company builds up inventory, it may mean it is having difficulties selling its goods.
Inventory Turnover measures how fast the company turns over its inventory within a year.
RxSight's Inventory Turnover for the
three
months ended in Mar. 2026 was 0.22.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
RxSight's Inventory-to-Revenue for the
three
months ended in Mar. 2026 was 1.08.
RxSight (NAS:RXST) Days Inventory Explanation
Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:
1. Inventory Turnover measures how fast the company turns over its inventory within a year.
RxSight's Inventory Turnover for the
three
months ended in Mar. 2026 is calculated as
2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
RxSight's Inventory to Revenue for the
three
months ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.
RxSight Days Inventory Related Terms
RxSight Days Inventory Historical Data
* Premium members only.
The historical data trend for RxSight's Days Inventory can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RXST vs LUCD, QTRX, INFU: Days Inventory Comparison
For the Medical Devices subindustry, RxSight's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
RxSight Days Inventory vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, RxSight's Days Inventory distribution charts can be found below:
* The bar in red indicates where RxSight's Days Inventory falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RxSight (RXST) has a Days Inventory of 409.84 as of Mar. 2026. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on RxSight and its competitors. This is 133% above median its historical median of 175.58. Over the past decade, RxSight's Days Inventory has ranged from 150.78 to 649.00. According to the industry distribution chart, RxSight ranks #657 out of 788 companies in the Medical Devices & Instruments industry, placing it in the top 83.4%.
Is RxSight's Days Inventory too high?
RxSight's current Days Inventory of 409.84 is 133% above median its 10-year median of 175.58. Over the past 10 years, this metric has ranged from a low of 150.78 to a high of 649.00. The Medical Devices & Instruments industry median Days Inventory is 179.12. RxSight's value of 409.84 is 128.8% above this industry median. Based on the distribution chart, RxSight ranks #657 out of 788 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, RxSight has a GF Score™ of 68/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does RxSight's Days Inventory compare to LUCD and QTRX?
According to the Medical Devices & Instruments industry distribution chart, RxSight ranks #657 out of 788 companies for Days Inventory. This places RxSight in the lower half of its industry. The industry median Days Inventory is 179.12. RxSight's value of 409.84 is 128.8% above this benchmark. Historically, RxSight's own Days Inventory has ranged from 150.78 to 649.00 over the past decade. While the company's 10-year median is 175.58 vs. the industry median of 179.12, RxSight has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Medical Devices & Instruments company?
The median Days Inventory among Medical Devices & Instruments companies is 179.12, based on 788 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. RxSight's current Days Inventory of 409.84 is 128.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on RxSight and its competitors. For the Medical Devices & Instruments industry, the median Days Inventory is 179.12 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. RxSight's current Days Inventory is 409.84, which is 133% above median its own 10-year median of 175.58. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RxSight stock overvalued right now?
Based on GuruFocus' analysis, RxSight (RXST) is currently considered Possible Value Trap. The stock's GF Value™ is $35.80, compared to a current price of $4.95 — trading 86.2% below its estimated fair value. The current Days Inventory is 409.84, which is 133% above median its 10-year median of 175.58 and 128.8% above the Medical Devices & Instruments industry median of 179.12. RxSight's overall GF Score™ is 68/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For RxSight (RXST), the current Days Inventory is 409.84 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RxSight (RXST) Overvalued in 2026?
Based on GuruFocus' analysis, RxSight stock appears to be undervalued.
The current stock price of $4.95 is trading 86.2% below its estimated GF Value™ of $35.80.
GuruFocus considers RxSight to be Possible Value Trap.
Key valuation signals for RXST:
Days Inventory: 409.84 (133% above median its 10-year median of 175.58)
GF Value™: $35.80 vs. price of $4.95 (86.2% below fair value)
Industry Position: 128.8% above the Medical Devices & Instruments median (#657 of 788)
No single metric tells the full story. See the RXST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RxSight Inc is a commercial-stage medical technology company dedicated to improving the vision of patients following cataract surgery. It offers intraocular lens technology that enables doctors to customize and optimize visual acuity for patients after cataract surgery. The company operates and manages its business in one reportable segment, the research and development, manufacture, and sale of light adjustable lenses and related capital equipment.
68GF Score
Get the complete analysis for RXST
Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
RXST has been successfully added to your 
